PAVmed (PAVM)

• Market cap: $13M
• 1 day: 5.56%
• 5 days: 13.38%
• 1 month: 5.35%
• 3 months: 18.01%
• 6 months: -28.30%
• Year to date: 18.75%
• 1 year: -55.56%
• 5 years: -97.79%
• 10 years: -99.61%
• Sector: Healthcare
• Industry: Medical Devices

About: PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

Employees: 107

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

14% more funds holding

Funds holding: 22 [Q3] → 25 (+3) [Q4]

1.37% less ownership

Funds ownership: 10.77% [Q3] → 9.39% (-1.37%) [Q4]

53% less capital invested

Capital invested by funds: $1.38M [Q3] → $652K (-$726K) [Q4]

67% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 9

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $19.50 2,466% upside
• Avg. target: $19.50 2,466% upside
• High target: $19.50 2,466% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Ascendiant Capital Edward Woo 43% 1-year accuracy 37 / 87 met price target

2,466% upside $19.50

Buy Maintained

21 Apr 2025